Advertisement

Topics

Randomized Trial of Cannabidiol for Medically Refractory Seizures in Dravet Syndrome

14:05 EDT 20 Jun 2017 | AHC Media

In a double-blind study, 120 children and young adults with the Dravet syndrome and medically refractory seizures were assigned randomly to receive either cannabidiol or placebo, as well as their usual antiepileptic drugs/therapies. The primary finding was a significant decrease in convulsive seizure frequency during the 14-week treatment period for patients receiving cannabidiol compared to those receiving placebo.

Original Article: Randomized Trial of Cannabidiol for Medically Refractory Seizures in Dravet Syndrome

NEXT ARTICLE

More From BioPortfolio on "Randomized Trial of Cannabidiol for Medically Refractory Seizures in Dravet Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...